Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Impact of Histological Variants on Outcomes in Patients With Urothelial Carcinoma Treated With Pembrolizumab: A Propensity Score Matching AnalysisBJU Int 2021 Jun 10;[EPub Ahead of Print], M Kobayashi, S Narita, Y Matsui, S Kanda, Y Hidaka, H Abe, T Tsuzuki, K Ito, T Kojima, M Kato, S Hatakeyama, Y Matsushita, S Naito, M Shiga, M Miyake, Y Muro, S Nakanishi, Y Kato, T Shibuya, T Hayashi, H Yasumoto, T Yoshida, M Uemura, R Taoka, M Kamiyama, S Morita, T Habuchi, O Ogawa, H Nishiyama, H Kitamura, T Kobayashi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.